Roivant Sciences Ltd. ROIV
35.80
(0.33)
(0.91%)
as of 25 Sep
- Market cap
- $25.6B
- P/E
- 0.0×
Follow ROIV
| Mar '18 | Dec '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 | 0.00 | 1.93 | 0.00 | 0.00 |
P/S ratio |
— | — | 258.96 | 59.84 | 85.84 | 249.73 | 251.93 | 2,326.88 |
P/FCF ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | (58.09) | (22.44) | (29.37) | (75.32) | (42.41) | (117.33) |
P/B ratio |
— | — | 3.02 | 1.62 | 3.27 | 1.27 | 1.41 | 3.63 |
Price to Tangible BV |
— | — | 3.02 | 1.62 | 3.60 | 1.29 | 1.45 | 3.73 |
EV/Sales |
— | — | 176.49 | 26.38 | 65.27 | 64.71 | 94.86 | 1,846.48 |
EV/EBITDA |
— | — | 0.00 | 0.00 | 0.00 | 0.47 | 0.00 | 0.00 |
EV/Operating CF |
— | — | (7.61) | (2.15) | (4.74) | (2.77) | (3.28) | (20.33) |
EV/FCF |
— | — | (7.53) | (2.10) | (4.67) | (2.76) | (3.27) | (20.11) |
Quick Ratio |
— | 3.08 | 9.74 | 11.18 | 6.15 | 24.35 | 32.71 | 18.00 |
Current Ratio |
— | 3.58 | 9.99 | 11.64 | 6.60 | 25.24 | 33.47 | 18.37 |
Net Debt/EBITDA |
— | 3.73 | 1.83 | 1.38 | 1.09 | (1.34) | 4.94 | 8.39 |
Debt/Assets |
0.00% | 0.00% | 6.58% | 8.12% | 17.42% | 6.13% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.08 | 0.10 | 0.26 | 0.07 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.64 | 0.68 | 0.80 | 0.84 | (0.18) | 4.88 | 2.50 |
Capex/Depreciation |
— | — | 0.00 | (2.94) | (0.67) | (0.06) | (0.33) | (2.45) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | (66.40%) | (41.45%) | (55.34%) | 107.97% | (2.96%) | (5.72%) | |
| — | (0.19%) | (53.90%) | (32.67%) | (40.57%) | 90.49% | (2.72%) | (5.38%) | |
ROIC |
— | 0.00% | (868.68%) | (448.00%) | (211.69%) | 709.46% | (208.81%) | (32.17%) |
Return on Tangible Assets |
— | (27.12%) | (40.81%) | (42.52%) | (64.47%) | 67.11% | (3.54%) | (6.12%) |
Average Days of Receivables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34,035.81 |
Research and Development Expense of Revenue |
— | — | 3,499.72% | 1,126.74% | 1,016.59% | 1,425.61% | 1,894.51% | 8,254.38% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 1,092.15% | 1,401.86% | 979.94% | 1,272.07% | 2,035.62% | 7,390.63% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.02 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 357.04% | 1,021.88% | 355.39% | 610.24% | 994.83% | 4,190.86% |
Graham Net Nets |
— | — | 0.27 | 0.48 | 0.19 | 0.73 | 0.65 | 0.25 |
Graham Number |
— | — | 0.00 | 0.00 | 0.00 | 31.63 | 0.00 | 0.00 |
Earnings Yield |
— | — | (14.61%) | (25.82%) | (19.51%) | 51.77% | (2.38%) | (1.62%) |
Free Cash Flow Yield |
— | — | (9.05%) | (21.01%) | (16.27%) | (9.38%) | (11.53%) | (3.95%) |
Revenue per Share |
— | 0.00 | 0.04 | 0.08 | 0.09 | 0.04 | 0.04 | 0.01 |
Operating CF per Share |
— | 0.00 | (0.88) | (1.01) | (1.18) | (0.98) | (1.16) | (1.08) |
Capex per Share |
— | 0.00 | (0.01) | (0.03) | (0.02) | 0.00 | (0.01) | (0.01) |
Free Cash Flow per Share |
— | 0.00 | (0.89) | (1.04) | (1.20) | (0.98) | (1.16) | (1.09) |
Cash per Share |
— | 0.03 | 3.39 | 3.08 | 2.35 | 8.29 | 6.74 | 6.19 |
Shareholders Equity per Share |
— | 7.75 | 3.24 | 3.04 | 2.26 | 8.23 | 7.15 | 7.63 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 7.75 | 3.24 | 3.04 | 2.26 | 8.23 | 7.15 | 7.63 |
Free Cash Flow |
— | (0.25) | (557.94) | (695.16) | (856.08) | (766.65) | (844.05) | (758.56) |
Working Capital |
— | 1.42 | 1,968.03 | 1,962.16 | 1,526.14 | 6,465.07 | 4,850.65 | 4,886.14 |
Capital Expenditures |
— | — | (5.81) | (17.44) | (12.69) | (1.38) | (4.60) | (8.21) |
Net Current Asset Value |
— | (12.95) | 1,636.82 | 1,600.34 | 1,016.57 | 5,957.88 | 4,750.32 | 4,751.11 |
EV/EBIT |
— | — | 0.00 | 0.00 | 0.00 | 0.47 | 0.00 | 0.00 |
Capex to Sales |
— | — | 0.24 | 0.32 | 0.21 | 0.04 | 0.16 | 0.99 |
Net Profit Margin |
— | 0.00% | (3,400.86%) | (1,528.89%) | (1,646.59%) | 13,294.18% | (591.96%) | (3,629.19%) |
Price to Operating Income |
— | — | 0.00 | 0.00 | 0.00 | 1.82 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | 0.00 | 0.23 | 0.48 | 1.44 | 1.17 | 0.28 |
Cash ROIC |
— | (0.06%) | (13.05%) | (16.33%) | (23.85%) | (5.83%) | (8.45%) | (7.95%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
Accounts Payable Turnover |
— | — | 0.00 | 0.33 | 0.36 | 0.06 | 0.05 | 0.06 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | — | 3,646.45 | 1,407.85 | 1,051.79 | 3,202.37 | 9,492.00 | 5,113.41 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | — | — | 385.12 |
Average Payables |
— | — | — | 27.57 | 36.21 | 25.93 | 18.86 | 20.85 |
Average Assets |
— | 206.39 | 1,501.24 | 2,587.41 | 2,487.37 | 4,806.04 | 6,329.71 | 5,572.81 |
Average Common Equity |
— | — | 1,218.68 | 2,039.23 | 1,823.27 | 4,028.06 | 5,817.86 | 5,239.81 |
Columns are period end dates